Drug
Spinosad clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 2
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
ParaPRO LLC (4) · Aperta Biosciences, LLC (1) · Takeda (1) · Santen Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses spinosad is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935CompletedPhase 1TakedaNCT02497235Written as [18F]MNI-792 (tracer)
- A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.Active, not recruitingPhase 2Aperta Biosciences, LLCNCT06720896Written as APT-001 topical ophthalmic ointment (spinosad)
- Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial DefectCompletedPhase 2Santen Pharmaceutical Co., Ltd.NCT00988494Written as DE-105 ophthalmic solution
- Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice InfestationCompletedPhase 4ParaPRO LLCNCT01660321Written as spinosad
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head LiceCompletedPhase 3ParaPRO LLCNCT00545168Written as Spinosad
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head LiceCompletedPhase 3ParaPRO LLCNCT00545753Written as Spinosad
- Phototoxicity Potential of NatrOVA Creme Rinse - 1%CompletedPhase 1ParaPRO LLCNCT00591331Written as Spinosad (the active ingredient in NatrOVA)
Codes
What other systems call spinosad · ClinicalTrials.gg INT004279
- MeSH (NLM) C415329spinosadOne source NLM
- UNII (FDA) XPA88EAP6VSPINOSADConfirmed FDA, NLM
- RxNorm 299081One source FDA
- NCI Thesaurus C170381SpinosadOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C415329 | spinosad | One source NLM |
| UNII (FDA) | XPA88EAP6V | SPINOSAD | Confirmed FDA, NLM |
| RxNorm | 299081 | — | One source FDA |
| NCI Thesaurus | C170381 | Spinosad | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.